Sexually transmitted infections and sexual practices among injecting drug users in harm reduction centers in Catalonia

European Addiction Research

Volumn 17, Issue 5, 2011, Pages 271-278

  Folch, Cinta ^a,b,c   Casabona, Jordi ^a,b,c   Brugal, M Teresa ^b,d   Majó, Xavier ^e   Esteve, Anna ^a,b   Meroño, Mercè ^f   Gonzalez, Victoria ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e GENERALITAT DE CATALUNYA   (Spain)

^f Àmbit Prevenció Foundation Ciutat Vella District   (Spain)

Author keywords

Chlamydia trachomatis; Human immunodeficiency virus; Injecting drug users; Neisseria gonorrhoeae; Sexual behaviors

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; FEMALE; GONORRHEA; HARM REDUCTION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; IMMIGRANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SPAIN;

ADULT; AGE FACTORS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EMIGRANTS AND IMMIGRANTS; FEMALE; GONORRHEA; HARM REDUCTION; HUMANS; MALE; NEISSERIA GONORRHOEAE; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 84860393920     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000329931     Document Type: Article

References (36)

1. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR: Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet 2001; 357: 1397-1401.
2. Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE: Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Arch Intern Med 2001; 161: 1281-1288.
3. Centre d'Estudis Epidemiológics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya: Sistema integrat de vigiláncia epidemiológica de la SIDA/VIH/ITS a Catalunya (SIVES). Barcelona, Generalitat de Catalunya, Departament de Salut, 2008.
4. Vallejo F, Toro C, Brugal MT, de la Fuente L, Soriano V, Jiménez R, Ballesta R, Bravo MJ: Muy alta incidencia de VIH y VHC en jóvenes consumidores de heroína. Proceedings XXIV Reunión Científica Anual de la Sociedad Española de Epidemiología, 2006, p129 (Gac Sanit; n̊ 20, Espec Congr).
5. de la Fuente L, Bravo MJ, Toro C, Brugal MT, Barrio G, Soriano V, Vallejo F, Ballesta R, Project Itinere Group: Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Community Health 2006; 60: 537-542.
6. Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M: Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: A 19-year prospective cohort study. AIDS 2006; 20: 1771-1775.
7. Brugal MT, Pulido J, Toro C, de la Fuente L, Bravo MJ, Ballesta R, Soriano V, Barrio G, Vallejo F, Domingo-Salvany A, Castellano Y, Project Itinere Group: Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain. Eur Addict Res 2009; 15: 171-178.
8. Go VF, Frangakis C, Nam le V, Bergenstrom A, Sripaipan T, Zenilman JM, Celentano DD, Quan VM: High HIV sexual risk behaviors and sexually transmitted disease prevalence among injection drug users in Northern Vietnam: Implications for a generalized HIV epidemic. J Acquir Immune Defic Syndr 2006; 42: 108-115.
9. Abdala N, Krasnoselskikh TV, Durante AJ, Timofeeva MY, Verevochkin SV, Kozlov AP: Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia. Eur Addict Res 2008; 14: 19-25.
10. Castilla J, Barrio G, De la Fuente L, Belza MJ: Sexual behaviour and condom use in the general population of Spain, 1996. AIDS Care 1998; 10:667-676.
11. González M, Cebrián S, Nadal C, Sala L, Vall-llosera A, Delás J: Injecting drug users from Eastern Europe in Barcelona, Spain. Gac Sanit 2003; 17: 256-258.
12. Rachlis B, Brouwer KC, Mills EJ, Hayes M, Kerr T, Hogg RS: Migration and transmission of blood-borne infections among injection drug users: Understanding the epidemiologic bridge. Drug Alcohol Depend 2007; 90: 107-119.
13. Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM: Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex Transm Infect 2005; 81: 53-58.
14. Liebschutz JM, Finley EP, Braslins PG, Christiansen D, Horton NJ, Samet JH: Screening for sexually transmitted infections in substance abuse treatment programs. Drug Alcohol Depend 2003; 70: 93-99.
15. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE: Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005; 32: 446-453.
16. Kuyper LM, Lampinen TM, Li K, Spittal PM, Hogg RS, Schechter MT, Wood E: Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect 2004; 80: 531-535.
17. World Health Organization, Multi-City Study on Drug Injecting and Risk of HIV Infection: Programme on Substance Abuse-Final Report. Geneva, WHO, 1994.
18. Chohan BH, Lavreys L, Mandaliya KN, Kreiss JK, Bwayo JJ, Ndinya-Achola JO, Martin HL: Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva. Clin Diagn Lab Immunol 2001; 8: 346-348.
19. González V, Martró E, Folch C, Esteve A, Matas L, Montoliu A, Grifols JR, Bolao F, Tural C, Muga R, Parry JV, Ausina V, Casabona J: Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. Eur J Clin Microbiol Infect Dis 2008; 27: 121-126.
20. Folch C, Sanclemente C, Esteve A, Martró E, Molinos S, Casabona J, HIVITS-TS: Social characteristics, risk behaviours and differences in the prevalence of HIV/sexually transmitted infections between Spanish and immigrant female sex workers in Catalonia, Spain. Med Clin (Barc) 2009; 132: 385-388.
21. Reina J, Gutiérrez O, González-Cárdenas M, Berlanga R: Prevalencia de infección genital por Chlamydia trachomatis en la población general y en un grupo de prostitutas de Palma de Mallorca. Enferm Infecc Microbiol Clin 2004; 22: 439-441.
22. Andreu A, Pumarola T, Sanz B, Sobejano L, Xercavins J, Coll O, López MA, Codina G: Prevalence of Chlamydia trachomatis infection, as evaluated by molecular biology methods. Enferm Infecc Microbiol Clin 2002; 20: 205-207.
23. Latka MH, Metsch LR, Mizuno Y, Wu Y, Tobin KE, Metsch LR: Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: Role of personal and partnership influences. J Acquir Immune Defic Syndr 2006; 42: 222-228.
24. Folch C, Esteve A, Sanclemente C, Martro E, Lugo R, Molinos S, Gonzalez V, Ausina V, Casabona J: Prevalence of human immunodeficiency virus, Chlamydia trachomatis, and Neisseria gonorrhoeae and risk factors for sexually transmitted infections among immigrant female sex workers in Catalonia, Spain. Sex Transm Dis 2008; 35: 178-183.
25. Family Health International: Prevención de las infecciones de transmisión sexual. In: Satisfacción de las necesidades de los clientes jóvenes: Una guía para prestar servicios de salud reproductiva a los adolescentes (Internet). Family Health International; 2008 (cited 2010 Mar 2). Available from: Http://www. fhi.org/sp/RH/Pubs/servdelivery/ adolguide/ Chapter4.htm.
26. Todd CS, Earhart KC, Botros BA, Khakimov MM, Giyasova GM, Bautista CT, Carr JK, Sanchez JL: Prevalence and correlates of risky sexual behaviors among injection drug users in Tashkent, Uzbekistan. AIDS Care 2007; 19: 122-129.
27. Folch C, Merono M, Casabona J: Factors associated with sharing syringes among streetrecruited injecting drug users. Med Clin (Barc) 2006; 127: 526-532.
28. Buchanan D, Tooze JA, Shaw S, Kinzly ML, Heimer R, Singer M: Demographic, HIV risk behavior, and health status characteristics of 'crack'cocaine injectors compared to other injection drug users in three New England cities. Drug Alcohol Depend 2006; 81: 221-229.
29. Rachlis B, Brouwer KC, Mills EJ, Hayes M, Kerr T, Hogg RS: Migration and transmission of blood-borne infections among injection drug users: Understanding the epidemic bridge. Drug Alcohol Depend 2007; 90: 107-119.
30. Rottingen JA, Cameron DW, Garnett GP: A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: How much really is known? Sex Transm Dis. Oct 2001; 28: 579-597.
31. Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR: Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend 2009; 101: 88-91.
32. European Monitoring Centre for Drugs and Drug Addiction, Annual report 2009: The State of the Drugs Problem in Europe (Internet). Luxembourg, Publications Office of the European Union, 2009. http://www.emcdda. europa.eu/publications/annual-report/2009.
33. Delegación del Gobierno para el Plan Nacional sobre Drogas, Observatorio español sobre drogas. Informe n̊6. Madrid, Ministerio del Interior, 2003.
34. Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A, Itinere Project Group: Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction 2009; 104: 614-619.
35. Novelli LA, Sherman SG, Havens JR, Strathdee SA, Sapun M: Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend 2005; 77: 303-309.
36. Hadland SE, Kerr T, Marshall BD, Small W, Lai C, Montaner JS, Wood E: Non-injection drug use patterns and history of injection among street youth. Eur Addict Res 2010; 16: 91-98.